To gain further insight into the mechanisms mediating the anti‐tumour effect of MEK1‐hi EVs, we analysed the infiltrating immune cells in 9609‐MEK1‐low and 9609‐MEK1‐hi tumours (Figure 5a). This evidence concerns the gene MAP2K1 and neoplasm.